CompletedNCT02862366

Role of the Circulating Procoagulants Microparticles in the Hypercoagulability of MNP Ph1-

Studying Myeloproliferative neoplasm

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Lille Catholic University
Principal Investigator
Agnès Charpentier, MD, PhD
GHICL
Intervention
Blood sampling(other)
Enrollment
128 enrolled
Eligibility
18 years · All sexes
Timeline
20102016

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02862366 on ClinicalTrials.gov

Other trials for Myeloproliferative neoplasm

Additional recruiting or active studies for the same condition.

See all trials for Myeloproliferative neoplasm

← Back to all trials